TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that Good Supply, one of Canada’s most recognized cannabis brands, has launched its spring product lineup, a new seasonal product release designed to accelerate growth across high-performing formats, including high-potency vapes, flower, and expanded pre-roll offerings. Good Supply’ ...

Top 3 Canadian Cannabis Stocks to Watch in February 2026The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum. Because of that, Canadian operators with U.S. exposure are drawing attention. Many investors are watching companies positioned for cross-border expansion.Canada remains a mature recreational market. However, growth there has slowed compared to earlier ye ...

Tilray Brands (NASDAQ: TLRY) is focused on expanding its reach. The marijuana company has now branched out to include CBD products and alcohol, and has started to call itself "a global lifestyle and consumer packaged goods company." It's not a bad idea, given the headwinds in the marijuana space, but there are material risks to consider here. The marijuana market hasn't panned out as hoped The first big problem with Tilray Brands isn't actually specific to the company. It is a problem that the entire mar ...

Wall Street can be very unforgiving. Unfortunately, a stock doesn't remember prices it once traded at -- and prices can keep rising or falling. Investors have seen this firsthand with Tilray Brands (NASDAQ: TLRY), a once-promising cannabis stock. Its shares have declined 16% over the past year. Even worse, the stock is down by 74% over the past three years and 97% over the past five years. Why has Tilray stock struggled, and is it time that investors dump their shares? Where to invest $1,000 right now? Ou ...

Core Viewpoint - Tilray Brands is struggling to achieve profitability despite its diverse product offerings in the beverage, cannabis, and wellness industries, with significant competition and ongoing losses impacting its financial performance [1][4]. Group 1: Financial Performance - Tilray Brands' stock price has decreased by 99% from its all-time high, reflecting investor fatigue over the company's inability to generate profits [4]. - The company has been expanding aggressively into other areas, particularly alcohol, but this strategy has not yet resulted in positive earnings [4]. Group 2: Revenue Growth and Strategy - Tilray is focusing on revenue growth through aggressive brand acquisitions since 2021, which has led to increased revenue and potential synergies [5]. - However, the rising share count due to stock sales for cash or acquisitions is diluting existing shareholders and complicating profit generation [6]. Group 3: Investment Risks - The ongoing losses and aggressive acquisition strategy present high risks for investors, with the company having to take write-downs across all divisions [7]. - Investors are advised to be cautious and may benefit from observing the company's performance before committing capital [7].

Company Performance - Tilray Brands, Inc. (TLRY) closed at $7.75, reflecting a -1.77% change from the previous day, underperforming the S&P 500's gain of 0.69% [1] - Over the past month, shares of Tilray have decreased by 13.58%, while the Medical sector gained 0.77% and the S&P 500 lost 1% [1] Upcoming Earnings - The upcoming earnings release is anticipated, with an expected EPS of -$0.14, indicating an 86% growth compared to the same quarter last year [2] - Revenue is projected at $205.93 million, reflecting a 10.85% increase from the equivalent quarter last year [2] Annual Forecast - For the entire year, the Zacks Consensus Estimates forecast an EPS of -$0.56 and revenue of $871.99 million, indicating changes of -660% and +6.17% respectively compared to the previous year [3] Analyst Estimates - Recent modifications to analyst estimates for Tilray reflect shifting short-term business dynamics, with positive revisions indicating optimism about the business outlook [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Tilray Brands, Inc. at 3 (Hold) [6] Industry Context - The Medical - Products industry, part of the Medical sector, has a Zacks Industry Rank of 148, placing it in the bottom 40% of over 250 industries [7] - Research indicates that top-rated industries outperform the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Cannabis stocks have underperformed over the past five years, but recent positive regulatory changes in the U.S. may present long-term growth opportunities if the marijuana market expands significantly [1] Group 1: Canopy Growth - Canopy Growth is a leading player in the Canadian cannabis market with a diverse product portfolio, including dried cannabis flower, vapes, and edibles, and has a presence in multiple countries, including the U.S. [2] - Following President Trump's executive order to classify cannabis as a Schedule III substance, Canopy Growth may have expansion opportunities in the U.S. [3] - In Q3 2026, Canopy Growth reported net revenue of $54.62 million, a slight decrease of 0.3% year-over-year, but improved its net loss per share to $0.13 from $0.81 in the previous year [3] - If Canopy Growth can capitalize on U.S. opportunities and continue to reduce losses, it could yield strong returns [4] Group 2: Tilray Brands - Tilray Brands also has a comprehensive portfolio of cannabis products and operates in several countries, including the U.S., Germany, and Portugal, and has diversified into craft brewing and hemp-based products [5] - In Q2 of its 2026 fiscal year, Tilray reported net revenue of $217.5 million, a 3% year-over-year increase, while its net loss improved to $0.41 from $0.99 in the previous year [6] - Tilray is well-positioned to take advantage of emerging opportunities in the U.S. cannabis market, which could lead to significant share price increases if successful [6]

This story was originally published on Food Dive. To receive daily news and insights, subscribe to our free daily Food Dive newsletter. Cannabis and craft beer producer Tilray Brands has landed a licensing agreement with Carlsberg Group for the production, marketing and selling of the Danish brewing giant's beer portfolio in the U.S. The five-year agreement is set to begin in 2027, with an automatic renewal option for another five years subject to performance criteria, according to a press release Wednesd ...

Tilray Brands has struck a deal to brew for Carlsberg in the US. A statement from the US-based cannabis and drinks producer confirmed it will brew, sell and distribute Carlsberg brands including Carlsberg and 1664 across the country from January. The Danish brewing giant presently exports its beers to the US. According to the statement, the agreement lasts five years, and includes an automatic renewal for another five "subject to performance criteria". Tilray chairman and CEO Irwin Simon said: "This p ...

Core Viewpoint - Tilray Brands, Inc. has entered into an exclusive licensing agreement with the Carlsberg Group to produce, market, and distribute Carlsberg-branded beers in the U.S. starting January 1, 2027, enhancing Tilray's position in the beverage market [1][2][3]. Group 1: Agreement Details - The licensing agreement grants Tilray a multi-year license to produce and distribute Carlsberg®, Carlsberg Elephant®, 1664®, and Kronenbourg 1664 Blanc® beers in the U.S. with an initial five-year term and an automatic renewal for an additional five years based on performance [2]. - The agreement is set to commence on January 1, 2027, and is expected to deliver immediate scale and revenue growth as the Carlsberg portfolio is anticipated to drive volume growth and expand shelf presence [8]. Group 2: Strategic Implications - Tilray will utilize its brewing facilities and commercial expertise to enhance Carlsberg's market share in the U.S., which is the world's second-largest beer market [3]. - The partnership is expected to strengthen Tilray's beverage platform by combining Carlsberg's global brand recognition with Tilray's operational scale and quality standards [4]. Group 3: Operational Enhancements - The agreement will leverage Tilray's operational footprint across brewing, sourcing, packaging, and logistics to drive cost efficiencies and strengthen supply chain resilience [6]. - The collaboration is projected to enhance Tilray's product mix and distributor positioning, thereby reinforcing its category leadership in the U.S. beverage market [8]. Group 4: Company Background - Tilray Beverages is a division of Tilray Brands, which has a diverse portfolio of craft beers, spirits, and non-alcoholic beverages, focusing on expanding premium and mainstream offerings across the U.S. [7]. - Carlsberg Group, founded in 1847, is one of the world's leading brewing companies with a presence in over 150 markets and employs more than 37,000 people globally [6].